Triple therapy with first generation HCV protease inhibitors: Lead-in or no lead-in phase?
Keyword(s):
2014 ◽
Vol 46
(1)
◽
pp. 18-24
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 115
◽
pp. 443-449
◽
2018 ◽
Vol 123
(1)
◽
pp. 50-56
◽
Keyword(s):
Patients treated with first-generation HCV protease inhibitors exhibit high ribavirin concentrations
2015 ◽
Vol 55
(5)
◽
pp. 517-524
◽
Keyword(s):
2016 ◽
Vol 28
(1)
◽
pp. 37-41
◽
2011 ◽
Vol 68
(15)
◽
pp. 1372-1379